Last reviewed · How we verify
Marcaine 0.5 % Injectable Solution
At a glance
| Generic name | Marcaine 0.5 % Injectable Solution |
|---|---|
| Also known as | Study |
| Sponsor | Barzilai Medical Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Effect of Scalp Block on Intraoperative Hemodynamics and Postoperative Pain in Craniotomy Patients" (NA)
- Repeated Bilateral Greater Occipital Nerve Blockade in Chronic Migraine and Chronic Tension-Type Headache (NA)
- Postop Pain Management in Pituitary Tumour Patients (PHASE4)
- Effect of Paracervical Block on Postoperative Pain After vNOTES Uterosacral Ligament Suspension (NA)
- Bupivacaine for Postoperative Pain After Laparoscopic Hysterectomy (NA)
- Efficacy of Nerve Blocks for Episodic Migraine (PHASE2)
- Comparison of Erector Spinae Plane Block and Caudal Block in Pediatric Patients Aged 1 to 8 Years Undergoing Lower Abdominal Surgery (NA)
- Efficacy of Transversus Abdominis Plane Block in Alleviating Acute Appendicitis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |